Psoriasis is a chronic inflammatory immune-mediated illness that mostly affects the skin and joints. Its negative consequences on patients’ physical, psychological, and emotional well-being result in a considerable loss in quality of life (QoL). The treatment aims are to reduce disease severity and improve patients’ QoL; achieving these goals needs clinicians to comprehend both the entire impact of the disease on a patient’s life and the outcomes that are most important to patients. The use of outcome measures can help physicians evaluate illness burden and its impact on QoL, as well as discover patient treatment preferences, eventually improving quality of care. Current outcome measures, on the other hand, have significant limitations and do not fully reflect patients’ needs and priorities. Nonetheless, clinicians treating psoriasis patients are advised to use these tools while being aware of their limits. 

Since there is no agreement on an outcome measure that fully captures the complexity of psoriasis and its impact on patients, dermatologists and their patients should be given instruments that are relevant and pertinent to them.